IFNG and neoplasm: Wargo demonstrated that the demethylating agent 5-Aza-2′-deoxycytidine used alone or in combination with depsipeptide increased the expression of tumor antigen NY-ESO-1 on tumor cells, resulting in increased IFN-γ responses by antigen specific (NY-ESO-1+) T cells [64].